Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Comment by canadapieton Apr 05, 2022 11:38am
124 Views
Post# 34576848

RE:RE:So anything good coming out soon

RE:RE:So anything good coming out soonIf results show some positive effect, wouldn't there be more "signs" ??? Sick patients should show "positive progress" and many on the trial would know that!
The lacklustre behavior of the Management and the depressed share price says it all! 

So, mediocre results at best, share price stays = or down, and another long waiting period!!
So evidently, another O O at a ridiculously low price!  And Management doesn't care because they have no vested intrest........!!!! 

But hey, good luck!! 

SPCEO1

I have had my complaints about management but doing nothing is not one of those complaints. As JFM repeatedly reminds us, you have to wait for a trial to be over to make claims the market will pay attention to. But if you are short the stock, as would appear to be the case given the tenor of your posts, you had better be careful because the overdue trial results cannot be postponed much longer. And patient #2 gives us good reason to believe the results will contain information the market may like. They have not yet set a date for the AGM but it is a situation where the results are highly likely to be out  on the phase 1a before then. It is not a situation that looks promising for shorts - the company has indicated to investors it has something in TH-1902 and we will likely know the details surrounding that soon. In a best case scenario, which is admittedly unlikely, they could  have the trial's results next Wednesday. You might want to be careful if you are short.  


Biobob wrote:Th management behaving like NATO in Ukraine... doing nothing... but how could they, the market is not good now, they have no news yet from Anderson, they can't tell us anything before AGM so that we don't send them in retirement, so that theu can execute their final solution.. OO no.2 in the confort of reelection.  
 
<< Previous
Bullboard Posts
Next >>